1. Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis 
Ashwani K. Singal, Amanpal Singh, Sathya Jaganmohan, Praveen Guturu, Rajasekhara Mummadi, Yong–Fang Kuo, Gagan K. Sood 
Clinical Gastroenterology and Hepatology 
Volume 8, Issue 2, Pages (February 2010)
DOI: /j.cgh
Copyright © 2010 AGA Institute Terms and Conditions

2. Figure 1 Literature search and study selection process.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

3. Figure 2
Forrest plot for HCC development in patients with HCV cirrhosis: comparison of treated patients with antiviral therapy (IFN or IFN and RBV) and untreated patients.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

4. Figure 3
Forrest plot for HCC development in patients with HCV cirrhosis: comparison of SVR and nonresponders (NSVR) after antiviral therapy (IFN or IFN and RBV).
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

5. Figure 4
Forrest plot for HCC development in patients with HCV cirrhosis who did not respond to initial antiviral therapy (IFN or IFN and RBV): comparison of maintenance IFN and controls or no treatment.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions